These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 23777472)
21. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403 [TBL] [Abstract][Full Text] [Related]
22. Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers. Adoga JO; Channa ML; Nadar A Biomed Pharmacother; 2021 Dec; 144():112323. PubMed ID: 34656062 [TBL] [Abstract][Full Text] [Related]
23. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts. Yang JH; Qi YF; Jia YX; Pan CS; Zhao J; Yang J; Chang JK; Tang CS Peptides; 2005 Mar; 26(3):501-7. PubMed ID: 15652657 [TBL] [Abstract][Full Text] [Related]
24. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction. Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291 [TBL] [Abstract][Full Text] [Related]
25. Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis. Zhao L; Shi H; Zhang F; Xue H; Han Q Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3411-3424. PubMed ID: 37955689 [TBL] [Abstract][Full Text] [Related]
26. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro. Chang JH; Jin MM; Liu JT Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987 [TBL] [Abstract][Full Text] [Related]
27. The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification. Li M; Chen L; Liu X; Wu Y; Chen X; Chen H; Zhong Y; Xu Y Biomed Pharmacother; 2024 Aug; 177():117048. PubMed ID: 38959606 [TBL] [Abstract][Full Text] [Related]
28. Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation. Rani N; Arya DS Eur J Pharmacol; 2020 Sep; 883():173389. PubMed ID: 32707190 [TBL] [Abstract][Full Text] [Related]
29. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress. Li J; Zhao Y; Zhou N; Li L; Li K J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285 [TBL] [Abstract][Full Text] [Related]
30. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway. Deng C; Sun Z; Tong G; Yi W; Ma L; Zhao B; Cheng L; Zhang J; Cao F; Yi D PLoS One; 2013; 8(3):e58371. PubMed ID: 23505496 [TBL] [Abstract][Full Text] [Related]
31. (-)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions. Wu Y; Xia ZY; Zhao B; Leng Y; Dou J; Meng QT; Lei SQ; Chen ZZ; Zhu J Int J Mol Med; 2017 Aug; 40(2):389-399. PubMed ID: 28714516 [TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin-Mediated Cardiac Protection From Ischemia/Reperfusion Injury in Diabetic Rats Is Associated With Endothelial Nitric Oxide Synthase/Glucose Transporter-4 Signaling Pathway. Babiker F; Al-Kouh A J Cardiovasc Pharmacol; 2024 Sep; 84(3):319-330. PubMed ID: 39240727 [TBL] [Abstract][Full Text] [Related]
33. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice. Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032 [TBL] [Abstract][Full Text] [Related]
34. Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes. Baumgardt SL; Fang J; Fu X; Liu Y; Xia Z; Zhao M; Chen L; Mishra R; Gunasekaran M; Saha P; Forbess JM; Bosnjak ZJ; Camara AKS; Kersten JR; Thorp EB; Kaushal S; Ge ZD Cardiovasc Res; 2024 Oct; 120(12):1456-1471. PubMed ID: 39001869 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of endogenous intermedin augmented myocardial injury in rats with ischemia/reperfusion. Teng X; Bian Y; Cai Y; Duan X; Yuan F; Du J; Wu W; Wang X; Tang C; Qi Y Horm Metab Res; 2013 Mar; 45(3):206-12. PubMed ID: 23018870 [TBL] [Abstract][Full Text] [Related]
36. Carthamin Yellow Protects the Heart Against Ischemia/Reperfusion Injury With Reduced Reactive Oxygen Species Release and Inflammatory Response. Lu QY; Ma JQ; Duan YY; Sun Y; Yu S; Li B; Zhang GM J Cardiovasc Pharmacol; 2019 Sep; 74(3):228-234. PubMed ID: 31356540 [TBL] [Abstract][Full Text] [Related]
37. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. Chen C; Feng Y; Zou L; Wang L; Chen HH; Cai JY; Xu JM; Sosnovik DE; Chao W J Am Heart Assoc; 2014 Jan; 3(1):e000683. PubMed ID: 24390148 [TBL] [Abstract][Full Text] [Related]
38. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats. Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939 [TBL] [Abstract][Full Text] [Related]
39. DJ-1 preserves ischemic postconditioning-induced cardioprotection in STZ-induced type 1 diabetic rats: role of PTEN and DJ-1 subcellular translocation. Li W; Leng Y; Xiong Y; Li W; Cai Y; Xue R; Chen R; Lei S; Xia Z; Xia Z Cell Commun Signal; 2024 May; 22(1):252. PubMed ID: 38698453 [TBL] [Abstract][Full Text] [Related]
40. Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy. Feidantsis K; Mellidis K; Galatou E; Sinakos Z; Lazou A Nutr Metab Cardiovasc Dis; 2018 Sep; 28(9):952-961. PubMed ID: 30017436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]